Radiation Therapy for Askin Tumor with Pleural Involvement
Introduction to Radiation Therapy
- The National Comprehensive Cancer Network recommends definitive radiation to gross disease: 60 Gy or higher in 1.8-2.0 Gy fractions to macroscopic residual tumor, respecting normal tissue constraints 1, 5
- The National Comprehensive Cancer Network suggests adjuvant radiation post-resection: 45-54 Gy in conventional fractionation 3, 4
- The National Comprehensive Cancer Network advises a boost to positive margins (R1/R2 resection): 54-60 Gy with consideration of simultaneous integrated boost if using IMRT 4
Technical Approach
- The National Comprehensive Cancer Network recommends using intensity-modulated radiation therapy (IMRT) with CT simulation-guided planning for optimal target coverage while minimizing toxicity to critical structures 1, 2, 5
- The Journal of Clinical Oncology notes that IMRT provides superior dosimetry compared to 3D conformal techniques and reduces local relapse rates 6, 7
Critical Dosimetric Constraints
- The National Comprehensive Cancer Network states that the contralateral lung mean dose should be less than 8.5 Gy (absolute maximum) 1, 2, 5
- The Journal of Clinical Oncology recommends that the contralateral lung V20 should be ≤7% to avoid fatal pulmonary toxicity 8
- The Journal of Clinical Oncology suggests minimizing the contralateral lung V5 as much as possible (associated with pneumonitis risk) 8
Target Volume Definition
- The Journal of Thoracic Oncology defines the gross tumor volume (GTV) as all visible disease including pleural soft tissue lesions 3, 4
- The Journal of Thoracic Oncology defines the clinical target volume (CTV) as GTV plus 0.5-1.0 cm margin for microscopic extension, including chest wall involvement and pleural surfaces at risk 3
- The Journal of Thoracic Oncology defines the planning target volume (PTV) as CTV plus 0.5-1.0 cm for setup uncertainty 3, 4